申请人:Nakade Shinji
公开号:US20070167425A1
公开(公告)日:2007-07-19
A compound having an ability to bind to an S
1
P receptor (particularly EDG-6, preferably EDG-1 and EDG-6), for example, the compound represented by formula (I) of the present invention, a salt thereof, a solvate thereof or a prodrug thereof is useful for prevention and/or treatment of rejection of transplantation, graft-versus-host disease, autoimmune disease, allergic disease and the like.
wherein ring A is a cyclic group; ring B is a cyclic group which may have substituent(s); X is a spacer having 1 to 8 atoms in its main chain, etc.; Y is a spacer having 1 to 10 atoms in its main chain, etc.; n is 0 or 1, wherein when n is 0, m is 1 and R
1
is a hydrogen atom or a substituent, and wherein when n is 1, m is 0 or an integer of 1 to 7 and R
1
is a substituent, and wherein m is 2 or more, R
1
s are the same or different.
一种具有结合S1P受体的能力的化合物(特别是EDG-6,最好是EDG-1和EDG-6),例如本发明的式(I)所表示的化合物,其盐,溶剂合物或前药,对于预防和/或治疗移植排斥,移植物抗宿主病,自身免疫性疾病,过敏性疾病等是有用的。其中,环A是一个环状基团;环B是一个可能具有取代基的环状基团;X是具有1至8个原子的主链的间隔物等;Y是具有1至10个原子的主链的间隔物等;n为0或1,其中当n为0时,m为1且R1是氢原子或取代基,当n为1时,m为0或1至7的整数且R1是取代基,当m为2或更多时,R1相同或不同。